140 related articles for article (PubMed ID: 32648260)
1. Neuro-meningeal relapse in anaplastic large-cell lymphoma: incidence, risk factors and prognosis - a report from the European intergroup for childhood non-Hodgkin lymphoma.
Del Baldo G; Abbas R; Woessmann W; Horibe K; Pillon M; Burke A; Beishuizen A; Rigaud C; Le Deley MC; Lamant L; Brugières L
Br J Haematol; 2021 Mar; 192(6):1039-1048. PubMed ID: 32648260
[TBL] [Abstract][Full Text] [Related]
2. The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Oki Y
PLoS One; 2018; 13(3):e0191461. PubMed ID: 29538376
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of anaplastic large-cell lymphoma in children and adolescents: a retrospective multicenter survey study].
;
Zhonghua Er Ke Za Zhi; 2017 Mar; 55(3):194-199. PubMed ID: 28273702
[No Abstract] [Full Text] [Related]
4. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system involvement in anaplastic large cell lymphoma in childhood: results from a multicentre European and Japanese study.
Williams D; Mori T; Reiter A; Woessman W; Rosolen A; Wrobel G; Zsiros J; Uyttebroeck A; Marky I; Le Deley MC; Brugières L;
Pediatr Blood Cancer; 2013 Oct; 60(10):E118-21. PubMed ID: 23720354
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system relapse in a child with anaplastic large cell lymphoma: potential for new therapeutic strategies.
Raffa EH; Branson HM; Ngan B; Alexander S; Abla O
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1377. PubMed ID: 33822480
[TBL] [Abstract][Full Text] [Related]
7. CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series.
Ruf S; Hebart H; Hjalgrim LL; Kabickova E; Lang P; Steinbach D; Schwabe GC; Woessmann W
Pediatr Blood Cancer; 2018 Jun; 65(6):e27003. PubMed ID: 29512859
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC.
Strullu M; Thomas C; Le Deley MC; Chevance A; Kanold J; Bertrand Y; Jubert C; Dalle JH; Paillard C; Baruchel A; Lamant L; Michel G; Brugières L
Bone Marrow Transplant; 2015 Jun; 50(6):795-801. PubMed ID: 25822227
[TBL] [Abstract][Full Text] [Related]
9. Isolated central nervous system (CNS) relapse in a case of childhood systemic anaplastic large cell lymphoma without initial CNS involvement.
Mori T; Sugita K; Kimura K; Fuke T; Miura T; Kiyokawa N; Fujimoto J
J Pediatr Hematol Oncol; 2003 Dec; 25(12):975-7. PubMed ID: 14663283
[TBL] [Abstract][Full Text] [Related]
10. Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk.
Ait-Tahar K; Damm-Welk C; Burkhardt B; Zimmermann M; Klapper W; Reiter A; Pulford K; Woessmann W
Blood; 2010 Apr; 115(16):3314-9. PubMed ID: 20185586
[TBL] [Abstract][Full Text] [Related]
11. Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.
Damm-Welk C; Mussolin L; Zimmermann M; Pillon M; Klapper W; Oschlies I; d'Amore ES; Reiter A; Woessmann W; Rosolen A
Blood; 2014 Jan; 123(3):334-7. PubMed ID: 24297868
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract][Full Text] [Related]
13. ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population.
Huang L; Zhang F; Zeng J; Guo H; Liu S; Wei X; Chen F; Jiang X; Liang Z; Liu Y; Li W
Ann Hematol; 2018 Jan; 97(1):149-159. PubMed ID: 29150811
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic large cell lymphoma in children and adolescents.
Lowe EJ; Gross TG
Pediatr Hematol Oncol; 2013 Sep; 30(6):509-19. PubMed ID: 23758281
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system involvement in T-cell lymphoma: A single center experience.
Gurion R; Mehta N; Migliacci JC; Zelenetz A; Moskowitz A; Lunning M; Moskowitz C; Hamlin P; Horwitz S
Acta Oncol; 2016 May; 55(5):561-6. PubMed ID: 27046135
[TBL] [Abstract][Full Text] [Related]
16. Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood.
Pillon M; Gregucci F; Lombardi A; Santoro N; Piglione M; Sala A; D'Amore ES; De Santis R; Casale F; Zecca M; Mussolin L; Rosolen A;
Pediatr Blood Cancer; 2012 Nov; 59(5):828-33. PubMed ID: 22389307
[TBL] [Abstract][Full Text] [Related]
17. Disease site as a determinant of survival outcome in patients with systemic anaplastic lymphoma kinase positive anaplastic large cell lymphoma with extranodal involvement: an analysis of 1306 cases from the US National Cancer Database.
Nguyen KA; Su C; Bai HX; Zhang Z; Xiao R; Karakousis G; Zhang PJ; Zhang G
Br J Haematol; 2018 Apr; 181(2):196-204. PubMed ID: 29602182
[TBL] [Abstract][Full Text] [Related]
18. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S
Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068
[TBL] [Abstract][Full Text] [Related]
19. Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?
Tanaka M; Miura H; Ishimaru S; Furukawa G; Kawamura Y; Kozawa K; Yamada S; Ito F; Kudo K; Yoshikawa T
Pediatr Rep; 2023 May; 15(2):333-340. PubMed ID: 37368362
[TBL] [Abstract][Full Text] [Related]
20. Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy.
Steinherz P; Jereb B; Galicich J
J Clin Oncol; 1985 Sep; 3(9):1217-26. PubMed ID: 3861774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
